Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

B2B sales

- PMLiVE

dna boosts London offering

Healthcarecomms agency launches specialist PR unit

- PMLiVE

Clark Health Communications in Farringdon move

Expands into new London offices

- PMLiVE

AstraZeneca backs heart website

Works with charity HEART UK on How Young My Heart

Bristol-Myers Squibb (BMS) building

BMS pulls ahead of Merck in quarterly PD-1 inhibitor sales

Supports analysts prediction BMS' Opdivo will become market leader

- PMLiVE

Amgen gets FDA nod for virus-based melanoma therapy

Advisory committee votes in favour of drug after three month delay

- PMLiVE

Ardelyx appoints William Bertrand Jr to board of directors

Executive VP of Infinity Pharmaceuticals joins the team

- PMLiVE

Consultation begins on new patient access scheme

EMA hopes PRIME will improve development of prioritymedicines and ease access concerns

- PMLiVE

Vertex forges ties with gene editing firm CRISPR Therapeutics

Aims to find new treatments for genetic diseases such as cystic fibrosis

- PMLiVE

Amgen’s Imlygic recommended for European approval

First-in-class oncolytic immunotherapy wins CHMP positive opinion

- PMLiVE

Keytruda ups survival in lung cancer, misses secondary target

Data shows Keytruda fails to beat BMS' Opdivo

Clare

Lucid Group appoints new MD for Leading Edge

New MD at Leading Edge

Lucid Group Communications Limited

- PMLiVE

Choosing wisely

How to make the best of emerging markets

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links